Join Transform 2021 this July 12-16. Register for the AI event of the year.

Bar Harbor BioTechnology, a Bar Harbor, Me., developer of DNA and RNA analysis equipment, raised a “multimillion dollar” first round of funding, VentureWire reports. The round was lead by Borealis Ventures, and also involved Village Ventures.

Bar Harbor Bio is a spinout of the Jackson Laboratory, a research institute known for its large collection of genetically engineered mice. The company is developing lab equipment and software for quantitative polymerase chain reaction, or qPCR — a method for identifying and measuring the prevalence of genes and their activity, or “expression.”


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member